Use of optical coherence tomography to evaluate papilledema and pseudopapilledema

Seminars in Ophthalmology

Volumn 25, Issue 5-6, 2010, Pages 198-205

  Heidary, Gena ^a   Rizzo III, Joseph F ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

idiopathic intracranial hypertension; optical coherence tomography; papilledema; pseudotumor cerebri

Indexed keywords

CLINICAL EFFECTIVENESS; HUMAN; IDIOPATHIC INTRACRANIAL HYPERTENSION; IMAGE ANALYSIS; INTRACRANIAL HYPERTENSION; LONGITUDINAL STUDY; NEUROIMAGING; OPTICAL COHERENCE TOMOGRAPHY; PAPILLEDEMA; PRIORITY JOURNAL; PSEUDOPAPILLEDEMA; RETINA NERVE CELL; RETINAL THICKNESS; REVIEW; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TIME DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISION; VISUAL SYSTEM PARAMETERS;

HUMANS; INTRACRANIAL HYPERTENSION; PAPILLEDEMA; PSEUDOTUMOR CEREBRI; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 78649349007     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.3109/08820538.2010.518462     Document Type: Review

References (47)

1. Barboni P, Savini G, Valentino ML, Montagna P, Cortelli P, De Negri AM, Sadun F, Bianchi S, Longanesi L, Zanini M, de VA, and Carelli V. Retinal nerve fber layer evaluation by optical coherence tomography in Leber's hereditary optic neuropathy. Ophthalmology 2005;112: 120-126. (Pubitemid 40075330)
2. Bruce BB, Preechawat P, Newman NJ, Lynn MJ, and Biousse V. Racial differences in idiopathic intracranial hypertension. Neurology 2008; 70: 861-867.
3. Choi SS, Zawadzki RJ, Keltner JL, and Werner JS. Changes in cellular structures revealed by ultra-high resolution retinal imaging in optic neuropathies. Invest Ophthalmol Vis. Sci. 2008; 49: 2103-2119.
4. Contreras I, Noval S, Rebolleda G, and Munoz-Negrete FJ. Follow-up of nonarteritic anterior ischemic optic neuropathy with optical coherence tomography. Ophthalmology 2007a;114: 2338-2344.
5. Contreras I, Rebolleda G, Noval S, and Munoz-Negrete FJ. Optic disc evaluation by optical coherence tomography in nonarteritic anterior ischemic optic neuropathy. Invest Ophthalmol Vis. Sci. 2007b; 48: 4087-4092. (Pubitemid 351261033)
6. Danesh-Meyer HV, Carroll SC, Foroozan R, Savino PJ, Fan J, Jiang Y, and Vander HS. Relationship between retinal nerve fber layer and visual feld sensitivity as measured by optical coherence tomography in chiasmal compression. Invest Ophthalmol Vis. Sci. 2006;47: 4827-4835.
7. Danesh-Meyer HV, Papchenko T, Savino PJ, Law A, Evans J, and Gamble GD. In vivo retinal nerve fber layer thickness measured by optical coherence tomography predicts visual recovery after surgery for parachiasmal tumors. Invest Ophthalmol Vis. Sci. 2008; 49: 1879-1885.
8. Deleon-Ortega J, Carroll KE, Arthur SN, and Girkin CA. Correlations between retinal nerve fber layer and visual feld in eyes with nonarteritic anterior ischemic optic neuropathy. Am. J Ophthalmol 2007;143: 288-294.
9. Durcan FJ, Corbett JJ, and Wall M. The incidence of pseudo-tumor cerebri. Population studies in Iowa and Louisiana. Arch. Neurol. 1988;45: 875-877.
10. El-Dairi MA, Holgado S, O'Donnell T, Buckley EG, Asrani S, and Freedman SF. Optical coherence tomography as a tool for monitoring pediatric pseudotumor cerebri. J AAPOS 2007; 11: 564-570.
11. Friedman AH, Gartner S, and Modi SS. Drusen of the optic disc. A retrospective study in cadaver eyes. Br. J Ophthalmol 1975;59: 413-421.
12. Friedman DI and Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002; 59: 1492-1495.
13. Frisen L. Swelling of the optic nerve head: a staging scheme. J Neurol. Neurosurg. Psychiatry 1982;45: 13-18.
14. Gonzalez-Garcia AO, Vizzeri G, Bowd C, Medeiros FA, Zangwill LM, and Weinreb RN. Reproducibility of RTVue retinal nerve fber layer thickness and optic disc measurements and agreement with Stratus optical coherence tomography measurements. Am. J Ophthalmol 2009; 147: 1067-1074.
15. Hee MR, Izatt JA, Swanson EA, Huang D, Schuman JS, Lin CP, Puliafto CA, and Fujimoto JG. Optical coherence tomography of the human retina. Arch. Ophthalmol 1995;113: 325-332.
16. Hoye VJ, III, Berrocal AM, Hedges TR, III,and Maro-Quireza ML. Optical coherence tomography demonstrates subretinal macular edema from papilledema. Arch. Ophthalmol 2001;119: 1287-1290.
17. Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafto CA, et al. Optical coherence tomography. Science 1991;254: 1178-1181.
18. Johansson C and Lindblom B. The role of optical coherence tomography in the detection of pituitary adenoma. Acta Ophthalmol. 2009; 87: 776-779.
19. Johnson LN, Diehl ML, Hamm CW, Sommerville DN, and Petroski GF. Differentiating optic disc edema from optic nerve head drusen on optical coherence tomography. Arch. Ophthalmol 2009; 127: 45-49.
20. Karam EZ and Hedges TR. Optical coherence tomography of the retinal nerve fbre layer in mild papilloedema and pseudopapilloedema. Br. J Ophthalmol 2005;89: 294-298.
21. Kim TW and Hwang JM. Stratus OCT in dominant optic atrophy: features differentiating it from glaucoma. J Glaucoma. 2007;16: 655-658.
22. Leung CK, Cheung CY, Weinreb RN, Qiu Q, Liu S, Li H, Xu G, Fan N, Huang L, Pang CP, and Lam DS. Retinal nerve fber layer imaging with spectral-domain optical coherence tomography: a variability and diagnostic performance study. Ophthalmology 2009; 116: 1257-1263.
23. Lorentzen SE. Drusen of the optic disk. A clinical and genetic study. Acta Ophthalmol (Copenh) Suppl. 1966; 1-180.
24. Lueck C and McIlwaine G. Interventions for idiopathic intracranial hypertension. Cochrane. Database. Syst. Rev. CD003434.2005.
25. Medeiros FA, Moura FC, Vessani RM, and Susanna R, Jr. Axonal loss after traumatic optic neuropathy documented by optical coherence tomography. Am. J Ophthalmol 2003;135: 406-408.
26. Menke MN, Knecht P, Sturm V, Dabov S, and Funk J. Reproducibility of nerve fber layer thickness measurements using 3D fourier-domain OCT. Invest Ophthalmol Vis. Sci. 2008; 49: 5386-5391.
27. Ney JJ, Volpe NJ, Liu GT, Balcer LJ, Moster ML, and Galetta SL. Functional visual loss in idiopathic intracranial hypertension. Ophthalmology 2009; 116: 1808-1813.
28. Ophir A, Karatas M, Ramirez JA, and Inzelberg R. OCT and chronic papilledema. Ophthalmology 2005; 112: 2238.
29. Puliafto CA, Hee MR, Lin CP, Reichel E, Schuman JS, Duker JS, Izatt JA, Swanson EA, and Fujimoto JG. Imaging of macular diseases with optical coherence tomography. Ophthalmology 1995;102: 217-229.
30. Rebolleda G and Munoz-Negrete FJ. Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography. Invest Ophthalmol Vis. Sci. 2009;50: 5197-5200.
31. Sakata LM, eon-Ortega J, Sakata V, and Girkin CA. Optical coherence tomography of the retina and optic nerve-a review. Clin. Experiment. Ophthalmol 2009; 37: 90-99.
32. Sanchez-Tocino H, Bringas R, Iglesias D, Gonzalez-Perez A, and Del Villar-Galan R. Utility of optic coherence tomography (OCT) in the follow-up of idiopathic intracranial hypertension in childhood. Arch. Soc. Esp. Oftalmol. 2006;81: 383-389.
33. Savini G, Bellusci C, Carbonelli M, Zanini M, Carelli V, Sadun AA, and Barboni P. Detection and quantifcation of retinal nerve fber layer thickness in optic disc edema using stratus OCT. Arch. Ophthalmol 2006;124: 1111-1117.
34. Savino PJ, Glaser JS, and Rosenberg MA. A clinical analysis of pseudopapilledema. II. Visual feld defects. Arch. Ophthalmol 1979;97: 71-75.
35. Schuman JS, Hee MR, Puliafto CA, Wong C, Pedut-Kloizman T, Lin CP, Hertzmark E, Izatt JA, Swanson EA, and Fujimoto JG. Quantifcation of nerve fber layer thickness in normal and glaucomatous eyes using optical coherence tomography. Arch. Ophthalmol 1995;113: 586-596.
36. Schuman JS, Puliafto CA, and Fujimoto JG. (2004). Optical Coherence Tomography of Ocular Diseases. Thorofare: Slack Incorporated.
37. Sergott RC. Optical coherence tomography: measuring in-vivo axonal survival and neuroprotection in multiple sclerosis and optic neuritis. Curr. Opin. Ophthalmol 2005;16: 346-350.
38. Sergott RC, Frohman E, Glanzman R, and Al-Sabbagh A. The role of optical coherence tomography in multiple sclerosis: expert panel consensus. J Neurol. Sci. 2007;263: 3-14. (Pubitemid 350029827)
39. Smith JL. Whence pseudotumor cerebri? J Clin. Neuroophthalmol. 1985;5: 55-56.
40. Subei AM and Eggenberger ER. Optical coherence tomography: another useful tool in a neuro-ophthalmol-ogist's armamentarium. Curr. Opin. Ophthalmol 2009;20: 462-466.
41. Trip SA, Schlottmann PG, Jones SJ, Altmann DR, Garway-Heath DF, Thompson AJ, Plant GT, and Miller DH. Retinal nerve fber layer axonal loss and visual dysfunction in optic neuritis. Ann. Neurol. 2005;58: 383-391.
42. Wall M. Idiopathic intracranial hypertension. Semin. Ophthalmol 1995;10: 251-259.
43. Wall M and George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991;114 (Pt 1A): 155-180.
44. Wall M and White WN. Asymmetric papilledema in idio-pathic intracranial hypertension: prospective interocular comparison of sensory visual function. Invest Ophthalmol Vis. Sci. 1998;39: 134-142.
45. Wojtkowski M, Bajraszewski T, Gorczynska I, Targowski P, Kowalczyk A, Wasilewski W, and Radzewicz C. Ophthalmic imaging by spectral optical coherence tomography. Am. J Ophthalmol 2004;138: 412-419. (Pubitemid 39208568)
46. Wojtkowski M, Srinivasan V, Fujimoto JG, Ko T, Schuman JS, Kowalczyk A, and Duker JS. Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology 2005;112: 1734-1746. (Pubitemid 41400010)
47. Yi K, Mujat M, Sun W, Burnes D, Latina MA, Lin DT, Deschler DG, Rubin PA, Park BH, de Boer JF, and Chen TC. Imaging of optic nerve head drusen: improvements with spectral domain optical coherence tomography. J Glaucoma. 2009;18: 373-378.